351 related articles for article (PubMed ID: 25617806)
1. Role of Donor Activating KIR-HLA Ligand-Mediated NK Cell Education Status in Control of Malignancy in Hematopoietic Cell Transplant Recipients.
Nowak J; Kościńska K; Mika-Witkowska R; Rogatko-Koroś M; Mizia S; Jaskuła E; Polak M; Mordak-Domagała M; Lange J; Gronkowska A; Jędrzejczak WW; Kyrcz-Krzemień S; Markiewicz M; Dzierżak-Mietła M; Tomaszewska A; Nasiłowska-Adamska B; Szczepiński A; Hałaburda K; Hellmann A; Czyż A; Gil L; Komarnicki M; Wachowiak J; Barańska M; Kowalczyk J; Drabko K; Goździk J; Wysoczańska B; Bogunia-Kubik K; Graczyk-Pol E; Witkowska A; Marosz-Rudnicka A; Nestorowicz K; Dziopa J; Szlendak U; Warzocha K; Lange A;
Biol Blood Marrow Transplant; 2015 May; 21(5):829-39. PubMed ID: 25617806
[TBL] [Abstract][Full Text] [Related]
2. Prediction of NK Cell Licensing Level in Selection of Hematopoietic Stem Cell Donor, Initial Results.
Rogatko-Koroś M; Mika-Witkowska R; Bogunia-Kubik K; Wysoczańska B; Jaskuła E; Kościńska K; Nestorowicz K; Dziopa J; Szlendak U; Gwozdowicz S; Graczyk-Pol E; Lange A; Nowak J
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):63-71. PubMed ID: 27933342
[TBL] [Abstract][Full Text] [Related]
3. Role of donor HLA class I mismatch, KIR-ligand mismatch and HLA:KIR pairings in hematological malignancy relapse after unrelated hematopoietic stem cell transplantation.
Graczyk-Pol E; Rogatko-Koros M; Nestorowicz K; Gwozdowicz S; Mika-Witkowska R; Pawliczak D; Zubala M; Szlendak U; Witkowska A; Tomaszewska A; Nasilowska-Adamska B; Szczepinski A; Wojcik M; Halaburda K; Nowak J
HLA; 2018 Dec; 92 Suppl 2():42-46. PubMed ID: 30168290
[TBL] [Abstract][Full Text] [Related]
4. Impact of Donor Activating KIR Genes on HSCT Outcome in C1-Ligand Negative Myeloid Disease Patients Transplanted with Unrelated Donors-A Retrospective Study.
Neuchel C; Fürst D; Niederwieser D; Bunjes D; Tsamadou C; Wulf G; Pfreundschuh M; Wagner E; Stuhler G; Einsele H; Schrezenmeier H; Mytilineos J
PLoS One; 2017; 12(1):e0169512. PubMed ID: 28107369
[TBL] [Abstract][Full Text] [Related]
5. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
6. Molecular relapse monitoring reveals the domination of impaired NK cell education over impaired inhibition in missing KIR-ligand recognition in patients after unrelated hematopoietic stem cell transplantation for malignant diseases.
Nowak J; Witkowska A; Rogatko-Koroś M; Malinowska A; Graczyk-Pol E; Nestorowicz-Kałużna K; Flaga A; Szlendak U; Wnorowska A; Gawron A
HLA; 2024 Feb; 103(2):e15364. PubMed ID: 38312022
[TBL] [Abstract][Full Text] [Related]
7. Influence of Differently Licensed KIR2DL1-Positive Natural Killer Cells in Transplant Recipients with Acute Leukemia: A Japanese National Registry Study.
Arima N; Nakamura F; Yabe T; Tanaka J; Fuji S; Ohashi K; Fukuda T; Miyamura K; Iwato K; Eto T; Mori T; Kobayashi N; Hoshino T; Kato C; Kanamori H; Nakamae H; Atsuta Y; Morishima Y; Kanda Y
Biol Blood Marrow Transplant; 2016 Mar; 22(3):423-31. PubMed ID: 26456260
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infections are strongly dependent on activating and inhibitory KIR-HLA pairs after T-cell replate unrelated hematopoietic stem cell transplantation, the principles, and method of pairing analysis.
Nowak J; Gwozdowicz S; Graczyk-Pol E; Mika-Witkowska R; Rogatko-Koros M; Nestorowicz K; Szlendak U; Malinowska A; Kaczmarek B; Nasilowska-Adamska B; Tormanowska M; Szczurowska N; Szypnicki J; Witkowska A; Lasota M; Malinowska E; Halaburda K
HLA; 2019 Dec; 94 Suppl 2():40-48. PubMed ID: 31758851
[TBL] [Abstract][Full Text] [Related]
9. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
[TBL] [Abstract][Full Text] [Related]
10. Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.
Zhao XY; Yu XX; Xu ZL; Cao XH; Huo MR; Zhao XS; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
Blood Adv; 2019 Dec; 3(24):4312-4325. PubMed ID: 31869417
[TBL] [Abstract][Full Text] [Related]
11. KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.
Boudreau JE; Giglio F; Gooley TA; Stevenson PA; Le Luduec JB; Shaffer BC; Rajalingam R; Hou L; Hurley CK; Noreen H; Reed EF; Yu N; Vierra-Green C; Haagenson M; Malkki M; Petersdorf EW; Spellman S; Hsu KC
J Clin Oncol; 2017 Jul; 35(20):2268-2278. PubMed ID: 28520526
[TBL] [Abstract][Full Text] [Related]
12. The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients.
Khanuntong S; Kuptawintu P; Upaisilpsathaporn K; Poolchareon A; Bunworasate U; Hirankarn N
HLA; 2016 Jun; 87(6):422-31. PubMed ID: 27273744
[TBL] [Abstract][Full Text] [Related]
13. The impact of KIR2DS4 gene on clinical outcome after hematopoietic stem cell transplantation.
Burek Kamenaric M; Stingl Jankovic K; Grubic Z; Serventi Seiwerth R; Maskalan M; Nemet D; Mikulic M; Zunec R
Hum Immunol; 2017 Feb; 78(2):95-102. PubMed ID: 27998801
[TBL] [Abstract][Full Text] [Related]
14. The effect of killer cell immunoglobulin-like receptor genotype on outcome of hematopoietic stem cell transplantation from matched sibling.
Elfishawi SM; Mossallam GI; El-Fattah RA; El-Haddad A; Kamel AM
Hum Immunol; 2017 Nov; 78(11-12):684-691. PubMed ID: 28993188
[TBL] [Abstract][Full Text] [Related]
15. The importance of natural killer cell killer immunoglobulin-like receptor-mismatch in transplant outcomes.
Stringaris K; Barrett AJ
Curr Opin Hematol; 2017 Nov; 24(6):489-495. PubMed ID: 28817402
[TBL] [Abstract][Full Text] [Related]
16. Recipient-donor KIR ligand matching prevents CMV reactivation post-haploidentical T cell-replete transplantation.
Zhao XY; Luo XY; Yu XX; Zhao XS; Han TT; Chang YJ; Huo MR; Xu LP; Zhang XH; Liu KY; Li D; Jiang ZF; Huang XJ
Br J Haematol; 2017 Jun; 177(5):766-781. PubMed ID: 28466469
[TBL] [Abstract][Full Text] [Related]
17. Resistance of KIR Ligand-Missing Leukocytes to NK Cells In Vivo in Patients with Acquired Aplastic Anemia.
Nguyen MAT; Hosokawa K; Yoroidaka T; Maruyama H; Espinoza JL; Elbadry MI; Mohiuddin M; Tanabe M; Katagiri T; Nakagawa N; Chonabayashi K; Yoshida Y; Arima N; Kashiwase K; Saji H; Ogawa S; Nakao S
Immunohorizons; 2020 Jul; 4(7):430-441. PubMed ID: 32680908
[TBL] [Abstract][Full Text] [Related]
18. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
[TBL] [Abstract][Full Text] [Related]
19. Decreased iKIR-HLA C Pair Confers Worse Clinical Outcomes for Patients With Myeloid Disease Receiving Antithymocyte Globulin-Based Haploidentical Hematopoietic Stem Cell Transplantation.
Zhao Y; Gao F; Wu Y; Shi J; Luo Y; Tan Y; Yu J; Lai X; Zhang M; Zhang W; Huang H
Front Immunol; 2020; 11():614488. PubMed ID: 33633734
[TBL] [Abstract][Full Text] [Related]
20. Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.
Sekine T; Marin D; Cao K; Li L; Mehta P; Shaim H; Sobieski C; Jones R; Oran B; Hosing C; Rondon G; Alsuliman A; Paust S; Andersson B; Popat U; Kebriaei P; Muftuoglu M; Basar R; Kondo K; Nieto Y; Shah N; Olson A; Alousi A; Liu E; Sarvaria A; Parmar S; Armstrong-James D; Imahashi N; Molldrem J; Champlin R; Shpall EJ; Rezvani K
Blood; 2016 Jul; 128(2):297-312. PubMed ID: 27247137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
